Companies / BOC Sciences / Rovelizumab
BOC Sciences

Rovelizumab | BOC Sciences

Rovelizumab is a humanized monoclonal leukointegrin antibody that targets CD11/CD18 cell adhesion proteins. Rovelizumab has been used in the research of multiple sclerosis, myocardial infarction and ischemic stroke.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.